Hubert e. Huckel MD

Filings by Hubert e. Huckel MD span 3 companies, the busiest being Valera Pharmaceuticals Inc, Catalyst Pharmaceuticals, Inc. and ThermoGenesis Holdings, Inc. In total, 28 filings cover trades dated from 2 February 2006 to 2 October 2014.

Market trades split into 14 purchases (€540k) and 7 sales (€158k). Taken together, the purchases exceed the sales by €381k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant and 5 option exercises.

A typical purchase (the median) is worth €24k. Ninety days after publication, 6 purchases show a median change of -9.1%, with the price up in 0% of them. These figures describe past trades and do not predict future prices.

Most recently, on 6 October 2014, the filings show a share grant in Catalyst Pharmaceuticals, Inc. The last purchase on record was published on 29 May 2012, which is 5,261 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.